Rite Aid (RAD) Feb. Front-End Comps Flat; Total Drugstore Sales Fell 3.7
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
Rite-Aid (RAD) Feb Sales Fall Victim to Choppy Trends, Shift in Flu Season
March 7, 2013 1:22 PM ESTGoldman Sachs today maintained a Neutral rating on Rite-Aid (NYSE: RAD) and raised its price target to $1.85 (from $1.70). This morning Rite-Aid reported light February sales, with noticeable little benefit from the intense flu season. Analysts believe that, while flu incidence remain elevated, the virus... More
